malignancies – Page 7 – Communicable Diseases Research

The Long-Term Characteristics of Immunity Conferred by COVID-19 Using Antibody Tests

Internal Medicine

Published on 2021-09-052022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] age anti-sars cov2 antibody anti-SARS-CoV-2 antibody anti-SARS-CoV-2 antibody test antibody Antibody Response association CAD Care Chronic kidney disease co-morbidities co-morbidity comorbities confirmed cases Coronary artery disease COVID-19 COVID-19 virus death Diabetes Mellitus dialysis disease Efficacy End-stage renal disease ESRD Gender General population HCW Health healthcare worker Healthcare workers high risk hypertension Immunity male malignancies malignancy natural immune response nosocomial COVID-19 nucleocapsid antigen objective Patient patients patients with haematological PCR persistence polymerase chain Population positive positive antibody response PROTECT Protective Protein Radiotherapy re-infected Re-infection Re-infections reactive Reinfection reported Result risk severe disease Sex Significant Symptom Symptoms Test the mean the patient
[DOI] 10.7759/cureus.17731 PMC 바로가기 [Article Type] Internal Medicine

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19

Review

Published on 2021-08-162022-10-31
Journal: Cancer Cell International [Category] COVID-19,

Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection

Pediatrics

Published on 2021-08-022022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

BNT162b2 COVID-19 mRNA 백신의 면역원성과 리투아니아 혈액암 환자의 초기 임상 결과: 국가 전향 코호트 연구

Article

Published on 2021-08-012022-09-12
Journal: The Lancet. Haematology [Category] MERS, SARS, 진단,

[키워드] Abbott Abstract Adverse Affect age allogeneic HSCT anti-CD20 antibody Antibody Response Architect autologous Biobank blood sample BNT162b2 BNT162b2 vaccine circulating Clinical outcome clinically Cohort Community Concentration Course COVID-19 death dose doses Efficacy evaluate event genotyping haematological malignancy Health health-care healthy heterogeneous highest IgG IgG antibody immunogenicity Infection Intervention Lithuania main analysis malignancies malignancy material median Microparticle mRNA vaccination mRNA vaccine National negatively affected of BNT162b2 Older participant Patient patients with haematological Pfizer-BioNTech prospective cohort study questionnaire Registered response responses ruxolitinib SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection SARS-CoV-2 vaccine second dose serological response seronegative serum severe SARS-CoV-2 subgroup therapy translation treated Treatment tyrosine kinase inhibitor university untreated patient vaccination vaccine dose vaccine doses venetoclax Vilnius was done was used were assessed
[DOI] 10.1016/S2352-3026(21)00169-1 PMC 바로가기 [Article Type] Article

Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective

Review

Published on 2021-07-162022-10-29
Journal: International Journal of Molecular Sciences [Category] Coronavirus, SARS,

Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate

Article

Published on 2021-07-162022-10-28
Journal: Vaccines [Category] COVID-19,

Management and Thinking on the Treatment of Cancer Patients During the COVID-19

Molecular Biosciences

Published on 2021-07-012022-10-31
Journal: Frontiers in Molecular Biosciences [Category] COVID-19,

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in hematology-oncology patients

혈액종양내과 환자의 중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 혈청전환

Article

Published on 2021-07-012022-09-12
Journal: Journal of medical virology [Category] MERS, SARS, 진단,

[키워드] acute respiratory syndrome Admission characterized China Cohort complications coronavirus death deaths described generate globe greater group hematological cancer hematological cancers ICU IgG immune immune response immune responses Immunocompromised patients Immunoglobulin increased risk infect Infection leukemia low seroconversion rate lymphoma malignancies mechanical ventilation morbidity Patient patients died PCR positive previous study receiving risk SARS Coronavirus SARS-CoV-2 SARS-CoV-2 IgG antibodies SARS-COV-2 infection screened Seroconversion Serological testing severe COVID-19 Severe infection Spread subsequent suggested tested the patient virus virus classification with COVID-19
[DOI] 10.1002/jmv.26886 PMC 바로가기 [Article Type] Article

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis

만성 B형 간염에 대한 치료 백신인 HeberNasvac은 선천 면역의 국소 및 전신 표지자를 자극합니다: SARS-CoV-2 노출 후 예방에 잠재적 사용

Article

Published on 2021-07-012022-09-11
Journal: Euroasian J Hepatogastroenterol [Category] 비임상,

[키워드] Acute respiratory infection acute respiratory infections acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antiviral antiviral properties antiviral property both sexes breath CHB chronic chronic hepatitis Chronic Hepatitis B clinical trial Cohort coronavirus coronavirus disease COVID-19 Dengue died Disease progression dose enrolled evidenced expression functional Hepatocellular carcinoma immune cells Immunity immunomodulating immunomodulatory immunomodulatory effect impairment increased expression Innate innate immune cell Innate immune cells Innate immunity intranasal lethal infection Local Lymphocytes malignancies malignancy marker material mice monocyte Monocytes mononuclear cell nasopharyngeal Older Open-label pandemic Patient patients PBMC Peripheral blood periphery Postexposure Postexposure Prophylaxis Potential presenting prophylactic therapy Prophylaxis randomized clinical trial reduction in respiratory infections Result Safe SARS-CoV-2 severe acute respiratory syndrome Coronavirus shown subjects surrogate markers Symptom symptoms of COVID-19 systemic the patient therapeutic therapy Toll-like receptor Toll-like receptors tonsils Treatment Vaccine
[DOI] 10.5005/jp-journals-10018-1344 PMC 바로가기 [Article Type] Article

The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity

Research Article

Published on 2021-06-282022-10-29
Journal: PLoS Pathogens [Category] COVID-19, MERS, SARS,

[키워드] Alpha Caco-2 Calu-3 Calu-3 cell line Cell cell line cell type cells cellular entry cellular protease Chronic diseases Colon comorbid disease comorbid diseases Comorbidity Control Coronaviruses COVID-19 outbreak COVID-19 patient COVID-19 patients dataset datasets death decrease described determine diabete diabetic patient disease disease severity down-regulated down-regulation downregulated drastic reduction Endocrine evaluated example expression Factor Features Health implication increase in inhibit inhibiting inhibitor kidney knockdown liver malignancies mechanism New coronavirus number of infected overexpressing overexpression pancreatic islet pandemic patients priming regulated Regulation S protein SARS-CoV-2 SARS-CoV-2 viral infection scRNA-seq data secretory cell serine protease inhibitor serine protease TMPRSS2 severity shown similarity SPINT2 susceptibility tissues TMPRSS2 triggered Tumor Type unique viral entry Viral load virulence virus while
[DOI] 10.1371/journal.ppat.1009687 PMC 바로가기 [Article Type] Research Article